Slate Stone Wealth, LLC Cytek Biosciences, Inc. Transaction History
Slate Stone Wealth, LLC
- $1.11 Billion
- Q3 2024
A detailed history of Slate Stone Wealth, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 14,895 shares of CTKB stock, worth $97,562. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,895
Previous 12,500
19.16%
Holding current value
$97,562
Previous $70,000
18.57%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
72.2MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77.1 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$62.2 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$43.6 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$27.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $882M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...